Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024
-
Avadel Pharmaceuticals and nference Announce Publication of Real-World Data in Sleep Advances
-
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 7, 2024
-
Blue Cross and Blue Shield of Minnesota Foundation Awards More Than $4m to 18 Nonprofits
-
Erasca Announces Strong Momentum for Naporafenib and RAS Targeting Franchise
-
Bryn Pharma Appoints Joshua Ziel as Chief Executive Officer
-
LifeVantage to Participate at the LD Micro Main Event XVII
-
Senseonics Holdings, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for November 7, 2024 at 4:30 P.M. Eastern Time
-
Hanmi Financial Declares Cash Dividend of $0.25 per share
-
LifeMD® to Report Third Quarter 2024 Financial Results on November 7
-
Apogee Therapeutics Announces Results Up to 9 Months from Phase 1 Trial of APG777, its Novel Half-Life Extended Anti-IL-13 Antibody for the Treatment for Atopic Dermatitis and Other Inflammatory Disea
-
ABM and Mainspring Energy Sign Strategic Partnership
-
Pharvaris Presents Clinical and Non-Clinical Data Supporting HAE Development Program at the 2024 ACAAI Annual Scientific Meeting
-
NANO Nuclear Energy Announces Pricing of Upsized $36 Million Underwritten Offering
-
Provectus Biopharmaceuticals Announces Investor Webinar for Fourth Quarter 2024 Conference Call
-
Bionano Announces Publication Outlining Utility of OGM for Resolution of MYC Gene Rearrangements in Multiple Myeloma
-
Arcutis Presents Positive Patient-Reported Outcome Data for ZORYVE® (Roflumilast) Cream 0.15% in Atopic Dermatitis at American College of Allergy, Asthma and Immunology 2024 Annual Scientific Meeting
-
Sonoco To Report Third Quarter 2024 Results
-
ENGIE announces Power Purchase Agreement with Google – Will supply power from its largest U.S. solar project to date
-
Aquestive Therapeutics Announces Positive Topline Results from Oral Allergy Syndrome (OAS) Challenge Study for Anaphylm™ (epinephrine) Sublingual Film
-
Key Advocates Urge CMS to Clarify that Fully Implanted Active Middle Ear Hearing Devices are Prosthetic Devices for Purposes of Medicare Coverage
-
Skyharbour Announces ANT Survey Prior to Upcoming Drill Program as well as Summary of 2024 Drilling to Date at Russell Lake Uranium Project, Northern Saskatchewan
-
Tri Pointe Homes Named to 2024 Fortune Best Workplaces for Women™ List for the Third Consecutive Year
-
Equipment Leasing and Finance Association CapEx Finance Index: September 2024
-
New Bluebeam Research Reveals Growing AI Use in Construction, but Regulatory and Talent Challenges Persist
-
CareCloud To Announce Third Quarter 2024 Results on November 12, 2024
-
authID to Report Third Quarter 2024 Financial Results on November 7, 2024
-
Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024
-
GoHealth to Announce Third Quarter 2024 Results on November 7, 2024
-
Nasdaq Giants and Rising Innovators Face Critical Earnings Reports This Quarter
-
Paycor Welcomes Industry Leader Dru Armstrong, CEO of AffiniPay, to Board of Directors
-
Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson’s Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 3
-
Paratus Sciences to Participate in the Longwood Healthcare Leaders Boston CEO Meeting
-
Legend Biotech to Host Investor Conference Call on Third Quarter 2024 Results
-
Absci to Participate in Upcoming Investor Conferences
-
Esperion to Report Third Quarter 2024 Financial Results on November 7
-
Press Release: Dupixent late-breaking positive phase 3 data in chronic spontaneous urticaria to be presented at ACAAI
-
Oma Savings Bank Plc’s Financial reporting and AGM in 2025
-
EDAP to Announce Third Quarter 2024 Financial Results on November 7, 2024
-
Independent Bank Corporation Reports 2024 Third Quarter Results
-
Columbia Financial, Inc. Announces Financial Results for the Third Quarter Ended September 30, 2024
-
Foodrella Tteokbokki Captivates Global Taste Buds
-
VCI Global Completes Founder Group Limited’s IPO on Nasdaq, Records US$5.2 Million in Revenue
-
Labrador Gold Announces Results of Summer Field Work at the Hopedale Project Including 32.32g/t Au at The North End of the 3km Thurber Gold Trend
-
McEwen Copper Announces an Additional US$35 Million Investment by Nuton, a Rio Tinto Venture
-
FirstService Reports Third Quarter 2024 Results
-
FTI Consulting Reports Third Quarter 2024 Financial Results
-
Orezone Provides Hard Rock Expansion Update for Its Bomboré Gold Mine
-
Kelly Announces Third-Quarter 2024 Conference Call
-
Kura Oncology Reports Preclinical Data Supporting Opportunity for Ziftomenib in Treatment of Gastrointestinal Stromal Tumors (GIST)
